TB-500 Research for Tissue Repair
An evidence-based overview of research examining TB-500 in the context of tissue repair. This page synthesizes findings from peer-reviewed literature.
Research Summary
Thymosin beta-4 is one of the most abundant intracellular proteins involved in tissue repair. Its primary mechanism involves binding to G-actin and regulating cytoskeletal dynamics, which is essential for cell migration during wound healing. Research from multiple laboratories globally (USA, UK, Germany, China) demonstrates accelerated wound healing in various tissue types including skin, cornea, and cardiac tissue. The peptide promotes angiogenesis and reduces inflammation through NF-kB suppression. The parent compound (Tb4) has Phase 2/3 clinical data, primarily in ophthalmology. TB-500 specifically lacks human clinical trials, and its efficacy may differ from the full-length protein.
Referenced Studies
Click any PMID to view the full study on PubMed.
Other Peptides Studied for Tissue Repair
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. TB-500 may have regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.